Sign up to save your podcasts
Or
Share E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
View all episodes
By Michael Putman
4.9
111111 ratings
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
322 Listeners
JAMA Clinical Reviews
505 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
Core IM | Internal Medicine Podcast
1,116 Listeners
Healio Rheuminations
120 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
362 Listeners
Freely Filtered, a NephJC Podcast
168 Listeners
ACR on Air
71 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
174 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
20 Listeners